Skip to content
healthcare.dev

ROMIDEPSIN

NDC 70121-2250, ROMIDEPSIN, injection, solution, concentrate, from Amneal Pharmaceuticals LLC.

Product NDC
70121-2250
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219099
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2250 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROMIDEPSIN5 mg/mL

Pharmacologic classes

Bile Salt Export Pump Inhibitors [MoA]; Histone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70121-2250-1701212250011 VIAL in 1 CARTON (70121-2250-1) / 5.5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/61894b77-f29c-4a81-ad85-bd3a698233a4
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70121-2250

Use it

Look up 70121-2250 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2250 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70121-2250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.